drugset / Trial / NCT00685841
A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
RandomizedParallel-groupTriple-blindTreatment
Summary
A 12 week study to investigate the safety and effectiveness of arformoterol given twice daily compared to placebo in subjects with COPD.
Timeline
- Start
- 2002-02
- Primary completion
- 2003-06
- Completion
- 2003-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Arformoterol | Small molecule | 15 ug | Inhaled |
| Subject | Arformoterol | Small molecule | 25 ug | Inhaled |
| Subject | Arformoterol | Small molecule | 50 ug | Inhaled |
| Comparator | Salmeterol | Other / unclassified | 42 ug | Inhaled |